All Stories

Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims

After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a public benefit company.

Mar 19, 2025 - 16:38
 0
Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a public benefit company.
Read More

Tags:

Previous Article

Wallbox achieves CTEP certification for its Supernova DC fast charger, marking m...

Next Article

Human medicines European public assessment report (EPAR): Pandemic influenza vac...

Related Posts

IRA round 2 begins as drugmakers sign on to price negotiation process with CMS

IRA round 2 begins as drugmakers sign on to price negot...

Mar 18, 2025  0

Want HCPs’ attention? Here’s what drug marketing messages resonate and when

Want HCPs’ attention? Here’s what drug marketing messag...

Mar 4, 2025  0

Johnson & Johnson CEO Joaquin Duato takes a 14% pay cut to $24.3M

Johnson & Johnson CEO Joaquin Duato takes a 14% pay cut...

Mar 12, 2025  0